Are exposure to cytomegalovirus and genetic variation on chromosome 6p joint risk factors for schizophrenia?
- PMID: 17453677
- DOI: 10.1080/07853890601083808
Are exposure to cytomegalovirus and genetic variation on chromosome 6p joint risk factors for schizophrenia?
Abstract
Background: Published data support genetic variants, as well as certain infectious agents, as potential risk factors for schizophrenia. Less is known about interactions between the risk factors.
Aim: To evaluate exposure to infectious agents and host genetic variation as joint risk factors.
Methods: We investigated four infectious agents: cytomegalovirus (CMV), herpes simplex viruses 1 and 2 (HSV1, HSV2), and Toxoplasma gondii (TOX). We initially compared exposure using specific serum antibodies, among simplex and multiplex nuclear families (one or more than one affected offspring, respectively). If interactions between infectious agents and host genetic variation are important risk factors for schizophrenia, we reasoned that they would be more prominent among multiplex versus simplex families. We also evaluated the role of variation at chromosome 6p21-p23 in conjunction with exposure. We used 22 short tandem repeat polymorphisms (STRPs) dispersed across this region.
Results: Though exposure to all four agents was increased among multiplex families versus simplex families, the difference was consistently significant only for CMV (odds of exposure to CMV in multiplex families: 2.47, 95% CI: 1.48-5.33). Transmission disequilibrium tests and case-control comparisons using STRPs revealed significant linkage/association with D6S2672 among CMV+ schizophrenia patients.
Conclusions: Polymorphisms near D6S2672 could confer risk for schizophrenia in conjunction with CMV exposure.
Similar articles
-
Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure.Schizophr Bull. 2012 Nov;38(6):1149-54. doi: 10.1093/schbul/sbs087. Epub 2012 Sep 10. Schizophr Bull. 2012. PMID: 22966150 Free PMC article.
-
Determining the IgM and IgG antibodies titer against HSV1, HSV2 and CMV in the serum of schizophrenia patients.Hum Antibodies. 2018 Feb 5;26(2):87-93. doi: 10.3233/HAB-170325. Hum Antibodies. 2018. PMID: 29036805
-
Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.Schizophr Res. 2008 Dec;106(2-3):268-74. doi: 10.1016/j.schres.2008.07.017. Epub 2008 Sep 17. Schizophr Res. 2008. PMID: 18801645 Free PMC article.
-
Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.Schizophr Bull. 2009 Nov;35(6):1163-82. doi: 10.1093/schbul/sbn054. Epub 2008 Jun 13. Schizophr Bull. 2009. PMID: 18552348 Free PMC article. Review.
-
HLA associations in schizophrenia: are we re-discovering the wheel?Am J Med Genet B Neuropsychiatr Genet. 2014 Jan;165B(1):19-27. doi: 10.1002/ajmg.b.32195. Epub 2013 Oct 19. Am J Med Genet B Neuropsychiatr Genet. 2014. PMID: 24142843 Review.
Cited by
-
Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci.Mol Psychiatry. 2014 Mar;19(3):325-33. doi: 10.1038/mp.2013.2. Epub 2013 Jan 29. Mol Psychiatry. 2014. PMID: 23358160 Free PMC article.
-
Nearest-neighbor Projected-Distance Regression (NPDR) for detecting network interactions with adjustments for multiple tests and confounding.Bioinformatics. 2020 May 1;36(9):2770-2777. doi: 10.1093/bioinformatics/btaa024. Bioinformatics. 2020. PMID: 31930389 Free PMC article.
-
The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.Mol Psychiatry. 2017 Nov;22(11):1554-1561. doi: 10.1038/mp.2017.151. Epub 2017 Aug 1. Mol Psychiatry. 2017. PMID: 28761078 Free PMC article. Review.
-
The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation.Clin Rev Allergy Immunol. 2010 Aug;39(1):51-61. doi: 10.1007/s12016-009-8170-x. Clin Rev Allergy Immunol. 2010. PMID: 19697163 Review.
-
An Early Developmental Marker of Deficit versus Nondeficit Schizophrenia.Schizophr Bull. 2019 Oct 24;45(6):1331-1335. doi: 10.1093/schbul/sbz024. Schizophr Bull. 2019. PMID: 31423529 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical